137 related articles for article (PubMed ID: 35413227)
1. Blockade of chloride channel-3 enhances cisplatin sensitivity of cholangiocarcinoma cells though inhibiting autophagy.
Han Y; Zhou Y; Zhou L; Jia X; Yu X; An X; Shi Z
Can J Physiol Pharmacol; 2022 Jul; 100(7):584-593. PubMed ID: 35413227
[TBL] [Abstract][Full Text] [Related]
2. Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS.
Qu X; Sheng J; Shen L; Su J; Xu Y; Xie Q; Wu Y; Zhang X; Sun L
PLoS One; 2017; 12(3):e0173712. PubMed ID: 28301876
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ClC-5 suppresses proliferation and induces apoptosis in cholangiocarcinoma cells through the Wnt/β-catenin signaling pathway.
Shi Z; Zhou L; Zhou Y; Jia X; Yu X; An X; Han Y
BMB Rep; 2022 Jun; 55(6):299-304. PubMed ID: 35651328
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Wnt/β-catenin signaling downregulates P-glycoprotein and reverses multi-drug resistance of cholangiocarcinoma.
Shen DY; Zhang W; Zeng X; Liu CQ
Cancer Sci; 2013 Oct; 104(10):1303-8. PubMed ID: 23822562
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells.
Seubwai W; Vaeteewoottacharn K; Kraiklang R; Umezawa K; Okada S; Wongkham S
Oncol Res; 2016 Jan; 23(1-2):21-8. PubMed ID: 26802647
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of active autophagy induces apoptosis and increases chemosensitivity in cholangiocarcinoma.
Hou YJ; Dong LW; Tan YX; Yang GZ; Pan YF; Li Z; Tang L; Wang M; Wang Q; Wang HY
Lab Invest; 2011 Aug; 91(8):1146-57. PubMed ID: 21647092
[TBL] [Abstract][Full Text] [Related]
7. Albendazole-induced autophagy blockade contributes to elevated apoptosis in cholangiocarcinoma cells through AMPK/mTOR activation.
He Q; Yin Y; Pan X; Wu Y; Li X
Toxicol Appl Pharmacol; 2022 Nov; 454():116214. PubMed ID: 36055539
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents.
Samatiwat P; Prawan A; Senggunprai L; Kukongviriyapan U; Kukongviriyapan V
Tumour Biol; 2016 Aug; 37(8):11495-507. PubMed ID: 27015836
[TBL] [Abstract][Full Text] [Related]
9. Natural compound oblongifolin C inhibits autophagic flux, and induces apoptosis and mitochondrial dysfunction in human cholangiocarcinoma QBC939 cells.
Zhang A; He W; Shi H; Huang X; Ji G
Mol Med Rep; 2016 Oct; 14(4):3179-83. PubMed ID: 27499017
[TBL] [Abstract][Full Text] [Related]
10. Capsaicin Enhances the Drug Sensitivity of Cholangiocarcinoma through the Inhibition of Chemotherapeutic-Induced Autophagy.
Hong ZF; Zhao WX; Yin ZY; Xie CR; Xu YP; Chi XQ; Zhang S; Wang XM
PLoS One; 2015; 10(5):e0121538. PubMed ID: 25933112
[TBL] [Abstract][Full Text] [Related]
11. YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation.
Huang CS; Zhu YQ; Xu QC; Chen S; Huang Y; Zhao G; Ni X; Liu B; Zhao W; Yin XY
Clin Transl Med; 2022 Jun; 12(6):e848. PubMed ID: 35696608
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma.
Suksawat M; Phetcharaburanin J; Klanrit P; Namwat N; Khuntikeo N; Titapun A; Jarearnrat A; Vilayhong V; Sa-Ngiamwibool P; Techasen A; Wangwiwatsin A; Mahalapbutr P; Li JV; Loilome W
Front Public Health; 2022; 10():766023. PubMed ID: 35223723
[TBL] [Abstract][Full Text] [Related]
13. Suppression of chloride channel 3 expression facilitates sensitivity of human glioma U251 cells to cisplatin through concomitant inhibition of Akt and autophagy.
Su J; Xu Y; Zhou L; Yu HM; Kang JS; Liu N; Quan CS; Sun LK
Anat Rec (Hoboken); 2013 Apr; 296(4):595-603. PubMed ID: 23408563
[TBL] [Abstract][Full Text] [Related]
14. Salubrinal Enhances Doxorubicin Sensitivity in Human Cholangiocarcinoma Cells Through Promoting DNA Damage.
Yu W; Xiang Y; Luo G; Zhao X; Xiao B; Cheng Y; Feng C; Duan C; Xia X; Wong VKW; Dai R
Cancer Biother Radiopharm; 2018 Aug; 33(6):258-265. PubMed ID: 29957018
[TBL] [Abstract][Full Text] [Related]
15. Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1.
Li J; Ma X; Xu F; Yan Y; Chen W
Pharm Biol; 2024 Dec; 62(1):314-325. PubMed ID: 38571483
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of retinoic acid receptor-β reverses drug resistance in cholangiocarcinoma cells by enhancing susceptibility to apoptosis.
Ren HY; Chen B; Huang GL; Liu Y; Shen DY
Mol Med Rep; 2016 Oct; 14(4):3602-8. PubMed ID: 27599527
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of autophagy improves resistance and enhances sensitivity of gastric cancer cells to cisplatin.
Hou G; Bai Y; Jia A; Ren Y; Wang Y; Lu J; Wang P; Zhang J; Lu Z
Can J Physiol Pharmacol; 2020 Jul; 98(7):449-458. PubMed ID: 32058824
[TBL] [Abstract][Full Text] [Related]
18. MRP3-Mediated Chemoresistance in Cholangiocarcinoma: Target for Chemosensitization Through Restoring SOX17 Expression.
Lozano E; Asensio M; Perez-Silva L; Banales JM; Briz O; Marin JJG
Hepatology; 2020 Sep; 72(3):949-964. PubMed ID: 31863486
[TBL] [Abstract][Full Text] [Related]
19. mir-637 inhibits the proliferation of cholangiocarcinoma cell QBC939 through interfering CTSB expression.
Li JX; Ding XM; Han S; Wang K; Jiao CY; Li XC
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1265-1276. PubMed ID: 29565483
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt/β-catenin signaling and inhibits apoptosis in cholangiocarcinoma.
Xue W; Dong B; Zhao Y; Wang Y; Yang C; Xie Y; Niu Z; Zhu C
Cell Oncol (Dordr); 2021 Dec; 44(6):1351-1361. PubMed ID: 34796468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]